leadf
logo-loader
NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Receive alerts
Market:
NASDAQ
Market Cap:
$818.78 m
Price
5.29 USD
Change
-5.37%
52 weeks high
13.39
52 weeks low
2.00

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.